CBRE Group, Inc. Reports Financial Results for Third-Quarter 2023
GAAP EPS Declined 56% to $0.61 Core EPS Declined 36% to $0.72 DALLAS–(BUSINESS WIRE)–CBRE Group, Inc. (NYSE:CBRE) today reported financial results for... Read more.
Global Drone Identification Systems Strategic Research Report 2023: Rising Evolution in Drone Technologies – From ID Systems to Military and Homeland Security Operations 2022-203 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Drone Identification Systems – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s... Read more.
Granite Construction to Participate in Investor Conferences
WATSONVILLE, Calif.–(BUSINESS WIRE)–Granite (NYSE: GVA) is pleased to announce its participation in a series of upcoming investor events where senior... Read more.
Booz Allen Hamilton Announces Second Quarter Fiscal 2024 Results
MCLEAN, Va.–(BUSINESS WIRE)–$BAH–Booz Allen Hamilton Holding Corporation (NYSE: BAH), the parent company of management and technology consulting... Read more.
Avery Dennison Declares Quarterly Dividend
MENTOR, Ohio–(BUSINESS WIRE)–#AVY–The Board of Directors of Avery Dennison Corporation (NYSE:AVY) has declared a quarterly cash dividend of $0.81... Read more.
Gorman-Rupp Announces Increase in Quarterly Cash Dividend
MANSFIELD, Ohio–(BUSINESS WIRE)–#Dividend–The Board of Directors of The Gorman-Rupp Company (NYSE: GRC) has declared a quarterly cash dividend... Read more.
Resco launches mobile solutions for Microsoft Power Platform
BOSTON & BRATISLAVA, Slovakia–(BUSINESS WIRE)–#microsoft—Resco, a pioneer in mobile technology with years of experience with cross-platform... Read more.
Gorman-Rupp Reports Third Quarter 2023 Financial Results
MANSFIELD, Ohio–(BUSINESS WIRE)–#EARNINGS–The Gorman-Rupp Company (NYSE: GRC) reports financial results for the third quarter ended September 30,... Read more.
nVent Announces Third Quarter 2023 Financial Results
Record sales and strong EPS; updating full-year guidance Reported sales of $859 million up 15%, organic up slightly Reported EPS of $0.63, up 15%; Adjusted EPS of... Read more.
ImmunoGen Announces European Medicines Agency Acceptance of Marketing Authorization Application for Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of... Read more.